Scientific Sessions 2025  /  Innovations in Valvular Heart Disease: Talks from Basic Science to Clinical Trials to Breakthrough Innovations in Surgical and Transcatheter Therapies  /  Next Generation for Transcatheter Innovations: Future Breakthroughs
Logo

American Heart Association

  57
  0

Final ID:

Next Generation for Transcatheter Innovations: Future Breakthroughs

  • Granada, Juan  ( CARDIOVASCULAR RESEARCH FOUNDATION , Orangeburg , New York , United States )
  • Leon, Martin  ( COLUMBIA UNIVERSITY MEDICAL CTR , New York , New York , United States )
  • Mack, Michael  ( Baylor heart Hospital , Plano , Texas , United States )
    • Author Disclosures:
    Juan Granada: DO have relevant financial relationships ; Other (please indicate in the box next to the company name): Co-Founder and Co-Inventor Cephea Valve Technologies (Abbott):Active (exists now) | Martin Leon: DO have relevant financial relationships ; Research Funding (PI or named investigator):Medtronic:Active (exists now) ; Individual Stocks/Stock Options:Ancora:Past (completed) ; Individual Stocks/Stock Options:Cathworks:Active (exists now) ; Research Funding (PI or named investigator):Edwards:Active (exists now) | Michael Mack: DO have relevant financial relationships ; Research Funding (PI or named investigator):Edwards Lifesciences:Active (exists now) ; Other (please indicate in the box next to the company name):Carmat- Corporate board:Active (exists now) ; Research Funding (PI or named investigator):Medtronic:Active (exists now)
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Innovations in Valvular Heart Disease: Talks from Basic Science to Clinical Trials to Breakthrough Innovations in Surgical and Transcatheter Therapies

Monday, 11/10/2025 , 09:45AM - 11:00AM

Cardiovascular Seminar

More abstracts on this topic:
At the Cutting-Edge: Surgical Innovations in Robotics for Valvular Heart Disease

Chikwe Joanna, Badhwar Vinay, Ramzy Danny, Bonatti Johannes

Innovations in AS Diagnosis by Electronic Provider Notification to Facilitate the Recognition and Management of Valvular Heart Disease

Tanguturi Varsha, Elmariah Sammy, Abou-karam Roukoz, Cheng Fangzhou

More abstracts from these authors:
Early TAVR Trial: Latest Updates of Early TAVR in Severe Asymptomatic Aortic Stenosis Patients

Genereux Philippe, Leon Martin, Mack Michael, Hahn Rebecca

Valvular Heart Disease Clinical Trials: What Does the Future Hold?

Enriquez-sarano Maurice, Mack Michael, Ogara Patrick, Leon Martin

You have to be authorized to contact abstract author. Please, Login
Not Available